Aisling Capital Management LP
CIK 0001766721
Annualised vol
48.63327%
Beta
0.79678
HHI
5391.067267
Top-10 weight
98.958245%
VaR 95%
4.254877%
VaR 99%
7.336679%
Max drawdown
74.686475%
Matched value
97.456834%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
No earlier 13F from this institution to compare with.
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| BBIO | BRIDGEBIO PHARMA INC | COM | 10806X102 | 341,834,227 | 72.48 | 4589611.0 | |
| GLUE | MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 37,647,069 | 7.98 | 1555664.0 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 28,785,379 | 6.1 | 1316806.0 | |
| CMPS | COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 20,267,554 | 4.3 | 1432336.0 | |
| BCAX | BICARA THERAPEUTICS INC | COM | 055477103 | 16,891,205 | 3.58 | 568919.0 | |
| - | BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | 107924102 | 7,757,297 | 1.64 | 1018018.0 | |
| - | SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 4,236,705 | 0.9 | 77031.0 | |
| URGN | UROGEN PHARMA LTD | COM | M96088105 | 3,974,400 | 0.84 | 108000.0 | |
| BMEA | BIOMEA FUSION INC | COM | 09077A106 | 3,011,673 | 0.64 | 2048757.0 | |
| ACRS | ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,298,267 | 0.49 | 434455.0 | |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | 2,148,250 | 0.46 | 325000.0 | |
| VTVT | VTV THERAPEUTICS INC | CL A NEW | 918385204 | 1,882,500 | 0.4 | 50000.0 | |
| MRKR | MARKER THERAPEUTICS INC | COM NEW | 57055L206 | 478,293 | 0.1 | 325370.0 | |
| OKUR | ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | 404,048 | 0.09 | 88607.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-13 | 471,616,868 | 14 | 48.63327 | 0.79678 | 74.686475 |
| 2026-03-31 | 2026-05-05 | 476,288,954 | 13 | |||
| 2025-12-31 | 2026-02-10 | 478,916,332 | 13 | |||
| 2025-09-30 | 2025-11-12 | 456,446,711 | 14 | |||
| 2025-03-31 | 2025-05-13 | 288,452,198 | 13 | |||
| 2024-12-31 | 2025-02-12 | 281,834,610 | 15 |